Twist Bioscience Revolutionizes Next-Generation Sequencing with IVDR Compliant Precision Dx Products

  The newly unveiled suite of Precision Dx Products includes the Twist Precision Prep and Enrichment Dx Kit, the Twist Precision Exome Dx Panel, and ...

March 07, 2024 | Thursday | News
Exonate's EXN407 Shows Promising Results in Phase Ib/IIa Trial for Diabetic Eye Diseases

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announ...

March 05, 2024 | Tuesday | News
Alamar Biosciences Partners with ALZpath to Advance Alzheimer's Diagnostic Solutions

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic supply agreemen...

March 04, 2024 | Monday | News
Inoviv Launches NeuroKey-3™: Pioneering Precision in Alzheimer's Biomarker Analysis

NeuroKey-3™ measures key biomarkers implicated in neurodegeneration, covering multiple aspects of Alzheimer's Disease and Dementia pathology, ...

March 04, 2024 | Monday | News
NeuroBo Gets Initial IRB Approval for Obesity Treatment Trial DA-1726

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases,  announced that...

March 01, 2024 | Friday | News
Exact Sciences Launches Riskguard™ Hereditary Cancer Test in the United States

The test is covered by Medicare and many commercial insurance plans for eligible patients   Exact Sciences Corp., a leading provider of cancer scree...

February 29, 2024 | Thursday | News
GE HealthCare Unveils Next-Generation LOGIQ Ultrasound Systems at European Congress of Radiology 2024

 For over three decades, LOGIQ has been at the forefront of ultrasound imaging, providing clinicians with reliable, high-quality solutions. The latest...

February 29, 2024 | Thursday | News
AbbVie and OSE Immunotherapeutics Forge Partnership to Develop Breakthrough Chronic Inflammation Treatment

Global license and collaboration agreement set to advance the development of OSE-230, a monoclonal antibody aimed at resolving chronic inflammation. ...

February 28, 2024 | Wednesday | News
FDA Expands Biktarvy® Indication for HIV Treatment

- Biktarvy Now First and Only INSTI-Based Single-Tablet Regimen That is FDA Approved and DHHS Guideline Recommended for People Who are Virologically ...

February 27, 2024 | Tuesday | News
Tevogen Bio Launches Genetic Predisposition Study for Long COVID Treatment Advancements

Tevogen Bio Holdings Inc. ('Tevogen Bio') (Nasdaq: TVGN) announces its strategic initiative to advance research into Long COVID treatment, unveiling plans ...

February 21, 2024 | Wednesday | News
Roche Diagnostics and BioPorto Announce Expanded Collaboration

    ProNephro AKI (NGAL) stands out as the first AKI biomarker test to secure FDA clearance for pediatric use, covering children from...

February 20, 2024 | Tuesday | News
Bayer AG and AskBio Initiate Phase II Trial of AB-1002 Gene Therapy for Congestive Heart Failure

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announ...

February 19, 2024 | Monday | News
CMR Surgical Appoints Industry Veteran to Lead Operations in Asia Pacific, Middle East, and Africa

CMR Surgical (CMR), a global leader in surgical robotics, has announced the appointment of Sushobhan Dasgupta as President and Chief Commercial Officer for...

February 19, 2024 | Monday | News
Roche Collaborates with PathAI to Enhance Digital Pathology Capabilities for Companion Diagnostics

PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion...

February 13, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close